Details
Stereochemistry | ACHIRAL |
Molecular Formula | C40H56 |
Molecular Weight | 536.8726 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 9 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C
InChI
InChIKey=OENHQHLEOONYIE-JLTXGRSLSA-N
InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+
Molecular Formula | C40H56 |
Molecular Weight | 536.8726 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 9 |
Optical Activity | NONE |
DescriptionCurator's Comment: Description was created based on several sources, including http://www.drugs.com/monograph/lumitene.html
Curator's Comment: Description was created based on several sources, including http://www.drugs.com/monograph/lumitene.html
Beta-carotene is found in many foods and is sold as a dietary supplement. Beta-carotene is a carotenoid, weak antioxidant; precursor of vitamin A, which is essential for vision and growth. Used to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (EPP). Has been used in high-dose antioxidant supplements containing ascorbic acid and vitamin E with zinc in high-risk patients with age-related macular degeneration. Beta-carotene is also used to decrease asthma symptoms caused by exercise; to prevent certain cancers, heart disease, cataracts; and to treat AIDS, alcoholism, Alzheimer’s disease, depression, epilepsy, headache, heartburn, high blood pressure, infertility, Parkinson’s disease, rheumatoid arthritis, schizophrenia, and skin disorders including psoriasis and vitiligo.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: free radicals |
|||
Target ID: singlet excited oxygen |
|||
Target ID: P20263 Gene ID: 18999.0 Gene Symbol: Pou5f1 Target Organism: Mus musculus (Mouse) Sources: http://www.ncbi.nlm.nih.gov/pubmed/25019987 |
|||
Target ID: Q09163 Gene ID: 13386.0 Gene Symbol: Dlk1 Target Organism: Mus musculus (Mouse) Sources: http://www.ncbi.nlm.nih.gov/pubmed/25019987 |
|||
Target ID: Q61221|||Q8R385 Gene ID: 15251.0 Gene Symbol: Hif1a Target Organism: Mus musculus (Mouse) Sources: http://www.ncbi.nlm.nih.gov/pubmed/25019987 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | SOLATENE Approved UseErythropoietic protoporphyria Launch Date1975 |
|||
Primary | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. | 1977 Sep |
|
Β-carotene inhibits neuroblastoma tumorigenesis by regulating cell differentiation and cancer cell stemness. | 2014 Aug 8 |
|
Cardiovascular effects of low versus high-dose beta-carotene in a rat model. | 2015 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.drugs.com/monograph/lumitene.html
For Erythropoietic Protoporphyria 0–300 mg (50,000–500,000 IU beta carotene) daily; For Macular Degeneration 15 mg daily in combination with ascorbic acid 500 mg daily, vitamin E 400 units daily, and zinc (as zinc oxide) 80 mg daily, with copper (as cupric oxide) 2 mg daily
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26225824
In vitro evaluation of BC (Beta-carotene) on rat H9c2 cells showed that the agent significantly improved vitality of these cells in a dose range of 2.5–10 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:05 GMT 2023
by
admin
on
Fri Dec 15 15:02:05 GMT 2023
|
Record UNII |
01YAE03M7J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A11CA02
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
WHO-VATC |
QA11CA02
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
LIVERTOX |
99
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
DSLD |
1016 (Number of products:99)
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
WHO-ATC |
D02BB01
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
JECFA EVALUATION |
INS-160A(III)
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
WHO-VATC |
QD02BB01
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-160A(III)
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
NCI_THESAURUS |
C68303
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
||
|
CFR |
21 CFR 184.1245
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
17579
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
BETA-CAROTENE
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
01YAE03M7J
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
19143
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000091819
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
SUB05791MIG
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
5280489
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
DB06755
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
C1016
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
m3125
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
4229
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL1293
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
Beta-Carotene
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
7235-40-7
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
3264
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
345
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
DTXSID3020253
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
1065480
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
62794
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
230-636-6
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
D019207
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY | |||
|
01YAE03M7J
Created by
admin on Fri Dec 15 15:02:05 GMT 2023 , Edited by admin on Fri Dec 15 15:02:05 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
page 594
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Nutritional value per 100 g (3.5 oz) - 361 μg
|
||
|
CONSTITUENT MAY BE PRESENT -> PARENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
ASSAY (HPLC)
Batch Data
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
page 594
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
USP
|
||
|
IMPURITY -> PARENT |
USP
|
||
|
IMPURITY -> PARENT |
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |